Director/PDMR Shareholding

RNS Number : 3558A
Globalworth Real Estate Inv Ltd
20 January 2020
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this information is considered to be in the public domain.

 

20 January 2020

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

Director/PDMR Shareholding

The Company announces that on 17 January 2020 Ioannis Papalekas, a director of the Company, sold 5,470,169 ordinary shares in the Company at a price of €9.85 per ordinary share cum dividend (€9.55 net of the interim dividend announced last week). 

Mr Papalekas remains a significant and committed shareholder in the Company with a holding of 23,734,670 ordinary shares, equivalent to 10.7 per cent of the issued ordinary share capital following the above transaction. 

 

The Notification of Dealing Form provided in accordance with the requirements of MAR in relation to the transaction listed above is set out below:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Ioannis Papalekas

2

 

Reason for the notification

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Globalworth Real Estate Investments Limited

b)

 

LEI

213800R3E823B1UBIA81

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of no par value

b)

Identification code 

 

GG00B979FD04

c)

 

Nature of the transaction 

 

 Sale of shares

d)

 

Price(s) and volume(s)

Price(s)

Volume(s)

€9.85

5,470,169

 

 

d)

 

Aggregated information 

- Aggregated volume

- Price

 

Not applicable, single transaction

e)

 

Date of the transaction 

17 January 2020

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

For further information visit www.globalworth.com or contact: 

Enquiries 

Stamatis Sapkas

Deputy Chief Investment Officer

 

Tel: +40 372 800 000

Jefferies (Joint Broker)

Stuart Klein

 

Tel: +44 20 7029 8000

Panmure Gordon (Nominated Adviser and Joint Broker)

Alina Vaskina

 

Tel: +44 20 7886 2500

Milbourne (Public Relations)

Tim Draper

Tel: +44 7903 802545

 

 

About Globalworth / Note to Editors:

Globalworth is a listed real estate company active in Central and Eastern Europe, quoted on the AIM-segment of the London Stock Exchange. It has become the pre-eminent office investor in the CEE real estate market through its market-leading positions both in Romania and in Poland. Globalworth acquires, develops and directly manages high-quality office and logistics/light-industrial real estate assets in prime locations, generating rental income from high quality tenants from around the globe. Managed by over 200 professionals across Romania and Poland, the combined value of its portfolio is €2.85 billion, as at 30 June 2019 pro forma for subsequent acquisitions. Over 95% of the portfolio is in income-producing assets, predominately in the office sector, and leased to a diversified array of some 685 national and multinational corporates. In Romania, Globalworth is present in Bucharest, Timisoara, Constanta and Pitesti, while in Poland its assets span Warsaw, Wroclaw, Lodz, Krakow, Gdansk and Katowice. For more information, please visit www.globalworth.com and follow us on Facebook, Instagram and LinkedIn.

                                                                                               

IMPORTANT NOTICE: This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom. This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBSGDBCDDDGGG
UK 100